Fri, February 25, 2022
Thu, February 24, 2022
Wed, February 23, 2022
Tue, February 22, 2022
Sun, February 20, 2022
Fri, February 18, 2022

Douglas Miehm Maintained (AUPH) at Buy with Decreased Target to $31 on, Feb 23rd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-31-on-feb-23rd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Douglas Miehm of RBC Capital, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Decreased Target from $34 to $31 on, Feb 23rd, 2022.

Douglas has made no other calls on AUPH in the last 4 months.



There are 3 other peers that have a rating on AUPH. Out of the 3 peers that are also analyzing AUPH, 0 agree with Douglas's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Douglas


  • Justin Kim of "Oppenheimer" Upgraded from Hold to Buy and Decreased Target to $31 on, Friday, December 10th, 2021
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $40 on, Thursday, November 4th, 2021
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $35 on, Thursday, November 4th, 2021

Publication Contributing Sources